Continuous Subcutaneous Use of Levetiracetam: A Retrospective Review of Tolerability and Clinical Effects

REFERENCES

• Morris HH, Estes LM, Gilmore R, Chronic intractable epilepsy as the only symptom of primary brain tumor. Epilepsia. 1993 Nov-Dec;34(6):1038–1043. PubMed PMID: 8243354. Epub 1993/11/01. eng.
   Google Scholar
• Hauser AW, Annegers FJ, Kurland TL. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia. 1993 May-Jun;34(3):453–468. PubMed PMID: 8504780. Epub 1993/05/01. eng.
   PubMed Web of Science ®Google Scholar
• Rona S, Rosenow F, Arnold S, A semiological classification of status epilepticus. Epileptic Disord. 2005 Mar;7(1):5–12. PubMed PMID: 15741134. Epub 2005/03/03. eng.
   Google Scholar
• Lorenzl S, Mayer S, Noachtar S, Nonconvulsive status epilepticus in terminally ill patients-a diagnostic and therapeutic challenge. J Pain Symptom Manage. 2008 Aug;36(2):200–205. PubMed PMID: 18395399. Epub 2008/04/09. eng.
   Google Scholar
• Corporation G. YouScript® Seattle, WA2013 [cited 2013 13.2.2013]. Available from: http://www.youscript.net/.
   Google Scholar
• Surges R, Volynski EK, Walker CM. Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited. Ther Adv Neurol Disord. 2008 Jul;1(1):13–24. PubMed PMID: 21180561. Pubmed Central PMCID: 3002539. Epub 2008/07/01. eng.
   Google Scholar
• Trinka E. What is the evidence to use new intravenous AEDs in status epilepticus? Epilepsia. 2011 Oct;52 Suppl 8:35–38. PubMed PMID: 21967358. Epub 2011/10/14. eng.
   PubMed Web of Science ®Google Scholar
• Feddersen B, Trinka, E. [Status epilepticus]. Nervenarzt. 2012 Feb;83(2):187–194. PubMed PMID: 22249602. Epub 2012/01/18. Status epilepticus. ger.
   Google Scholar
• Glien M, Brandt C, Potschka H, Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy. Epilepsia. 2002 Apr;43(4):350–7. PubMed PMID: 11952764. Epub 2002/04/16. eng.
   Google Scholar
• Lopez-Saca MJ, Vaquero J, Larumbe A, Repeated Use of Subcutaneous Levetiracetam in a Palliative Care Patient. J Pain Symptom Manage. 2013 Mar 24. PubMed PMID: 23535323. Epub 2013/03/29. Eng.
   Google Scholar
• Fonzo-Christe, Caroline, Vukasovic, Caroline, Wasilewski-Rasca, Anne-Florence, Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review. Palliative Medicine. 2005;19:208–219.
   Google Scholar
• Menahem S, Shvartzman, P. Continuous subcutaneous delivery of medications for home care palliative patients-using an infusion set or a pump? Support Care Cancer. 2010 Sep;18(9):1165–1170. PubMed PMID: 19787380. Epub 2009/09/30. eng.
   Google Scholar
• Mitten, Trevor. Subcutaneous drug infusions: a review of problems and solutions. International Journal of Palliative Nursing. 2001;7(2):75–85.
   Google Scholar
• Herndon MC, Fike SD. Continuous Subcutaneous Infusion Practices of United States Hospices. J Pain Symptom Manage. 2001 12/2001;22(6):1027–1034.
   Google Scholar
• Fisher SR, Boas vE W, Blume W, Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005 Apr;46(4):470–472. PubMed PMID: 15816939. Epub 2005/04/09. eng.
   PubMed Web of Science ®Google Scholar
• Mundipharma. Personal Communication. 2013.
   Google Scholar
• UCB. Personal Communication. 2010.
   Google Scholar
• Ege I, Feldmann F, Lambert K, Möller A, Nett C, Pecar A, PÄD i.v. 3 ed. München: Zuckschwerdt Verlag; 2009.
   Google Scholar
• Mbizvo KG, Dixon P, Hutton LJ, Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review. Cochrane Database Syst Rev. 2012;9:CD001901. PubMed PMID: 22972056. Epub 2012/09/14. eng.
   Google Scholar
• Misra KU, Kalita J, Maurya KP. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. Journal of neurology. 2012 Apr;259(4):645–648. PubMed PMID: 21898137. Epub 2011/09/08. eng.
   PubMed Web of Science ®Google Scholar
• Graham, F. Syringe drivers and subcutaneous sites: a review. European Journal of Palliative Care. 2006;13(4):138–141.
   Google Scholar
• Dunne K, Sullivan K, Garvey A, An audit of subcutaneous syringe drivers in a non-specialist hospital. Int J Palliat Nurs. 2000 May;6(5):214–219. PubMed PMID: 12419992.
   Google Scholar
• Wilcock A, Jacob KJ, Charlesworth S, Drugs given by a syringe driver: a prospective multicentre survey of palliative care services in the UK. Palliat Med. 2006 Oct;20(7):661–664. PubMed PMID: 17060264. Epub 2006/10/25. eng.
   Google Scholar
• Schneider JJ, Wilson MK, Ravenscroft JP. A study of the osmolality and pH of subcutaneous drug infusion solutions. Australian Journal of Hospital Pharmacy. 1997;27:29–31.
   Google Scholar
• Infusionzubereitungen Europäisches Arzneibuch (European Pharmacopoeia Ph Eur) 70 Ausgabe Grundwerk 2011 Band 1. 72011. p. 1100.
   Google Scholar
• Parenteralia 5.2/0520. Arzneibuchkommentar (European Pharmacopoeia Ph Eur; commentary) Gesamtwerk einschliesslich 43 Aktualisierungslieferung 2012. Stuttgart, Eschborn: Wissenschaftliche Verlagsgesellschaft Stuttgart Govi-Verlag GmbH; 2012.
   Google Scholar
• Jauch WK, Schregel W, Stanga Z, 9 Technik und Probleme der Zugänge in der parenteralen Ernährung. Aktuel Ernahrungsmed. 2007 04.03.2008;32(S 1):S41–S53. PubMed PMID: 101055S2006951876. De.
   Google Scholar
• UCB. Prescribing Information (German) Keppra® 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung: Rote Liste Service GmbH; 2014 [updated 01.2014; cited 2014 10.08.2014]. Available from: http://www.fachinfo.de
   Google Scholar